UK Early Access Granted For Argenx’s Generalized Myasthenia Gravis Treatment

Efgartigimod Is Being Investigated For Several High-Need Autoimmune Conditions

 
• By Vibha Sharma

Patients in the UK with generalized myasthenia gravis are being allowed to receive argenx’s yet-to-be approved drug efgartigimod.

Myasthenia gravis - Diagnosis written on a piece of white paper with medication and Pills
Generalized MG causes weakness in many muscle groups throughout the body • Source: Shutterstock

More from Rare Diseases

More from Pink Sheet